Data from 2 studies, LIGHTHOUSE and SPOTLIGHT, have shown the benefit of flotufolastat F 18 injection as a radiohybrid PSMA-targeted PET imaging agent in prostate cancer. The agent has now been added ...

The objective of androgen deprivation therapy (ADT) in men with prostate cancer is to maintain very low levels of testosterone so that the hormone does not promote tumor growth. But a new analysis ...

Your prostate is an organ that makes some of the fluid that’s part of semen. It’s below your bladder and in front of your rectum. Prostate cancer happens when the cells in your prostate gland grow out ...

Prostate-specific antigen velocity as a predictive biomarker in a prospective prostate cancer screening study (IMPACT study). This is an ASCO Meeting Abstract from the 2015 Genitourinary Cancers ...

Acute prostatitis is a sudden inflammation of the prostate gland. It is a rare type of prostatitis that can resemble a urinary tract infection. A doctor will typically prescribe antibiotics for acute ...

FDA approves Jevtana injection for prostate cancer Sanofi-aventis announced that the FDA has approved Jevtana (cabazitaxel injection) in combination with prednisone for the treatment of patients with ...

Prostatitis and BPH (benign prostatic hyperplasia) are distinct conditions affecting the prostate gland. Although both conditions involve the prostate, they have different causes, symptoms, treatments ...

Enzyme ablation of the hyperplastic prostate may be an ideal method of management of BPH. However, the unsatisfactory ablation affects in vivo contrast with successful in vitro results limiting the ...